Byfavo, the first anesthetic drug in 30 years, has settled on a general hospital prescription.

According to related industries, Hana Pharmaceutical's Byfavo passed the Drug Commission (DC) of Big 5 General Hospitals, including Seoul National University Hospital, Asan Medical Center, and Sinchon Severance Hospital. Byfavo is a new anesthetic drug released more than 30 years after the approval of the frequency prescription general anesthetic Propofol.

Byfavo, which was launched in March, secured manufacturing rights and exclusive sales rights from Germany's Paion in 2013. Since 2018, phase 3 clinical trials have been completed for 198 subjects who perform general anesthesia in Korea.